|
1
|
Hassan MK, Watari H, Christenson L,
Bettuzzi S and Sakuragi N: Intracellular clusterin negatively
regulates ovarian chemoresistance: compromised expression
sensitizes ovarian cancer cells to paclitaxel. Tumour Biol.
32:1031–1047. 2011. View Article : Google Scholar
|
|
2
|
McGuire WP 3rd and Markman M: Primary
ovarian cancer chemotherapy: current standards of care. Br J
Cancer. 89(Suppl 3): S3–S8. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ozols RF and Young RC: Chemotherapy of
ovarian cancer. Semin Oncol. 11:251–263. 1984.
|
|
4
|
Dai Z, Huang Y and Sadée W: Growth factor
signaling and resistance to cancer chemotherapy. Curr Top Med Chem.
4:1347–1356. 2004.PubMed/NCBI
|
|
5
|
Fuchs J, Habild G, Leuschner I, Schweinitz
DV, Haindl J and Knop E: Paclitaxel: an effective antineoplastic
agent in the treatment of xenotransplanted hepatoblastoma. Med
Pediatr Oncol. 32:209–215. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heney M, Alipour M, Vergidis D, et al:
Effectiveness of liposomal paclitaxel against MCF-7 breast cancer
cells. Can J Physiol Pharmacol. 88:1172–1180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pisters KM, Vallières E, Crowley JJ, et
al: Surgery with or without preoperative paclitaxel and carboplatin
in early-stage non-small-cell lung cancer: Southwest Oncology Group
Trial S9900, an intergroup, randomized, phase III trial. J Clin
Oncol. 28:1843–1849. 2010. View Article : Google Scholar
|
|
8
|
Selimovic D, Hassan M, Haikel Y and Hengge
UR: Taxol-induced mitochondrial stress in melanoma cells is
mediated by activation of c-Jun N-terminal kinase (JNK) and p38
pathways via uncoupling protein 2. Cell Signal. 20:311–322. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fojo T and Menefee M: Mechanisms of
multidrug resistance: the potential role of microtubule-stabilizing
agents. Ann Oncol. 18(Suppl 5): v3–v8. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roberti A, La Sala D and Cinti C: Multiple
genetic and epigenetic interacting mechanisms contribute to
clonally selection of drug-resistant tumors: current views and new
therapeutic prospective. J Cell Physiol. 207:571–581. 2006.
View Article : Google Scholar
|
|
11
|
Leonard GD, Fojo T and Bates SE: The role
of ABC transporters in clinical practice. Oncologist. 8:411–424.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gottesman MM and Ling V: The molecular
basis of multidrug resistance in cancer: the early years of
P-glycoprotein research. FEBS Lett. 580:998–1009. 2006.PubMed/NCBI
|
|
13
|
Li Z, Hu S, Wang J, et al: MiR-27a
modulates MDR1/P-glycoprotein expression by targeting HIPK2 in
human ovarian cancer cells. Gynecol Oncol. 119:125–130. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu MD, Xu JC, Fan Y, Xie QC, Li Q, Zhou
CX, Mao M and Yang Y: Hypoxia-inducible factor 1 promoter-induced
JAB1 overexpression enhances chemotherapeutic sensitivity of lung
cancer cell line A549 in an anoxic environment. Asian Pac J Cancer
Prev. 13:2115–2120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bourguignon LY, Spevak CC, Wong G, Xia W
and Gilad E: Hyaluronan-CD44 interaction with protein kinase
C(epsilon) promotes oncogenic signaling by the stem cell marker
Nanog and the Production of microRNA-21, leading to down-regulation
of the tumor suppressor protein PDCD4, anti-apoptosis, and
chemotherapy resistance in breast tumor cells. J Biol Chem.
284:26533–26546. 2009.
|
|
18
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
19
|
Hilpert F, Krause G, Venhoff L, Kuhnle E,
Schem C and Maass N: Epithelial ovarian cancer. Ther Umsch.
64:375–380. 2007.(In German).
|
|
20
|
Li H, Hui L, Xu W, et al: Triptolide
modulates the sensitivity of K562/A02 cells to adriamycin by
regulating miR-21 expression. Pharm Biol. 50:1233–1240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Zhu X, Gu J, et al: Anti-miR-21
oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide
by inducing apoptosis. Cancer Sci. 101:948–954. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Zhu X, Gu J, et al: Anti-miR-21
oligonucleotide enhances chemosensitivity of leukemic HL60 cells to
arabinosylcytosine by inducing apoptosis. Hematology. 15:215–221.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nardinocchi L, Puca R and D’Orazi G:
HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2
degradation. Aging (Albany NY). 3:33–43. 2011.
|
